Skip to main content
. Author manuscript; available in PMC: 2007 Jan 4.
Published in final edited form as: Diabetes Care. 2006 Sep;29(9):1997–2002. doi: 10.2337/dc06-0454

Table 1.

Overall comparison of medication adherence by demographic factors

Metformin
Placebo
Demographic characteristics n Percent adherent n Percent adherent
Age (years)
 25–44 293 65.9 302 70.1
 45–59 519 72.5 530 77.3
 ≥60 208 70.6 192 81.0
P value 0.01 0.0001
Sex
 Male 348 73.7 316 78.4
 Female 672 68.4 708 74.9
P value 0.01 0.07
Ethnicity/race
 Caucasian 577 73.4 550 80.7
 African American 209 66.4 211 67.0
 Hispanic 150 65.0 158 73.0
 American Indian 52 67.5 59 72.1
 Asian 32 68.5 46 75.3
P value 0.008 <0.0001
Income*
 <$20,000 126 60.1 146 76.8
 $20,000 to <$35,000 165 66.1 181 75.6
 $35,000 to <$50,000 203 74.7 206 74.6
 $50,000 to <$75,000 212 70.0 201 78.6
 ≥$75,000 231 77.2 210 78.6
 Refused 82 64.7 80 65.1
P value <0.0001 0.01
Marital status
 Never married 126 67.4 127 77.8
 Living together 29 62.4 44 75.7
 Married 632 72.5 636 75.5
 Separated 31 64.6 27 68.9
 Divorced 152 67.3 145 77.2
 Widowed 50 65.8 45 77.3
P value 0.09 0.72
Education (years)
 ≤12 258 68.8 270 76.2
 13–16 484 69.6 497 75.1
 ≥17 278 72.6 257 77.2
P value 0.33 0.66
*

The adherence difference between metformin and placebo is consistent across age, sex, ethnicity, marital status, and education. However, heterogeneity is observed for income levels (P = 0.01). Those with <$20,000 income had the biggest gap in adherence between metformin and placebo.